IDEXX Laboratories (NASDAQ: IDXX) is one of 25 public companies in the “Diagnostic substances” industry, but how does it compare to its competitors? We will compare IDEXX Laboratories to similar businesses based on the strength of its institutional ownership, risk, earnings, profitability, analyst recommendations, dividends and valuation.
This table compares IDEXX Laboratories and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|IDEXX Laboratories Competitors||-885.83%||-65.54%||-25.27%|
Earnings & Valuation
This table compares IDEXX Laboratories and its competitors revenue, earnings per share and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|IDEXX Laboratories||$1.97 billion||$263.14 million||60.31|
|IDEXX Laboratories Competitors||$308.36 million||$13.85 million||-44.55|
IDEXX Laboratories has higher revenue and earnings than its competitors. IDEXX Laboratories is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Risk and Volatility
IDEXX Laboratories has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500. Comparatively, IDEXX Laboratories’ competitors have a beta of 1.44, indicating that their average share price is 44% more volatile than the S&P 500.
Institutional and Insider Ownership
87.5% of IDEXX Laboratories shares are held by institutional investors. Comparatively, 52.8% of shares of all “Diagnostic substances” companies are held by institutional investors. 2.6% of IDEXX Laboratories shares are held by company insiders. Comparatively, 13.5% of shares of all “Diagnostic substances” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
This is a breakdown of recent ratings and target prices for IDEXX Laboratories and its competitors, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|IDEXX Laboratories Competitors||102||373||571||19||2.48|
IDEXX Laboratories currently has a consensus price target of $190.67, indicating a potential downside of 3.62%. As a group, “Diagnostic substances” companies have a potential upside of 16.41%. Given IDEXX Laboratories’ competitors higher possible upside, analysts plainly believe IDEXX Laboratories has less favorable growth aspects than its competitors.
IDEXX Laboratories beats its competitors on 8 of the 13 factors compared.
About IDEXX Laboratories
IDEXX Laboratories, Inc., together with its subsidiaries, develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. It operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments. The company provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. It also offers diagnostic and health-monitoring products for livestock, poultry, and dairy markets; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers that are used in the human point-of-care medical diagnostics market. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was founded in 1983 and is headquartered in Westbrook, Maine.
Receive News & Ratings for IDEXX Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEXX Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.